Trademark: 75601095
Status Date
Friday, February 8, 2013
Registration Number
2587053
Registration Date
Tuesday, July 2, 2002
Filing Date
Monday, December 7, 1998
Published for Opposition
Tuesday, September 28, 1999
Cancellation Date
Friday, February 8, 2013
5 "pharmaceuticals, namely anti-cancer preparation"
In the statement, Column 1, before line 1, INTROGEN THERAPEUTICS, INC. (DELAWARE CORPORATION) 301 CONGRESS AVENUE, SUITE 1850 AUSTIN, TX 78701, by assignment should be inserted.
Feb 8, 2013
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Nov 29, 2007
Case File In Ticrs
Sep 18, 2002
Certificate Of Correction Issued
Sep 19, 2002
Post Registration Action Mailed - Sec. 7
Aug 5, 2002
Request For New Certificate Filed
Aug 5, 2002
Paper Received
Jul 2, 2002
Registered-Principal Register
Jun 13, 2002
Teas Change Of Correspondence Received
May 16, 2002
Sec. 1(B) Claim Deleted
Jun 21, 2001
Notice Of Allowance Cancelled
Apr 30, 2002
Petition To Director - Granted
Mar 27, 2002
Communication Received From Petitioner
Mar 1, 2002
Petition Inquiry Letter Mailed
Dec 8, 2000
Petition To Director Received
Dec 8, 2001
Correspondence Received In Law Office
Feb 3, 2001
Extension 2 Granted
Dec 14, 2000
Extension 2 Filed
Aug 23, 2000
Extension 1 Granted
Jun 21, 2000
Extension 1 Filed
Dec 21, 1999
Noa Mailed - Sou Required From Applicant
Sep 28, 1999
Published For Opposition
Aug 27, 1999
Notice Of Publication
Jun 22, 1999
Approved For Pub - Principal Register
Apr 27, 1999
Non-Final Action Mailed
Apr 26, 1999
Assigned To Examiner
Apr 14, 1999
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
